FindTrial
Sign In

Application of double filtration plasmapheresis in the treatment of hypertriglyceridemic pancreatitis

Clinical effect analysis of double filtration plasmapheresis in the treatment of severe hypertriglyceridemic pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037754
Enrollment
Unknown
Registered
2020-09-04
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertriglyceridemic pancreatitis

Interventions

2:double filtration plasmapheresis

Sponsors

Ya 'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A patient with hyperlipidemia and pancreatitis was admitted to the Department of critical medicine, Ya'an people's hospital.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 16 years old; 2. Patients with heparin allergy; 3. Patients with systemic circulatory failure that are difficult to be corrected by drugs; 4. Patients with unstable heart and brain infarction; 5. Patients with cerebral hemorrhage or severe brain edema with cerebral hernia; 6. Patients with mental disorders; 7. Patients with severe coagulation disorders.

Design outcomes

Primary

MeasureTime frame
clinical outcome;—

Secondary

MeasureTime frame
Effective time of lipid clearance;length of stay;Hospitalization cost;—

Countries

China

Contacts

Public ContactMin Yang

Ya'an People's Hospital

550991614@qq.com18180005210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026